Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysisFrancisco M. Marty, Lindsey R. Baden, John Koreth et al.|Blood|2007Cited by 142